PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity
Effect of Tiplaxtinin (PAI-039), an Orally Bioavailable PAI-1 Antagonist, in a Rat Model of Thrombosis